Sleep disturbance after cessation of cannabis administration in mice
Abstract Cannabis withdrawal syndrome (CWS) in humans is characterized by various somatic symptoms, including sleep disturbances. In the present study, we investigated sleep alterations in mice after the cessation of arachidonylcyclopropylamide (ACPA), a cannabinoid type 1 receptor agonist, administ...
Main Authors: | Takashi Asano, Hiroki Takemoto, Tomoya Horita, Tomohiro Tokutake, Naotaka Izuo, Takatoshi Mochizuki, Atsumi Nitta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12329 |
Similar Items
-
The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review
by: Kevin M. Takakuwa, et al.
Published: (2021-02-01) -
Dose-dependent effects of celecoxib on CB-1 agonist-induced antinociception in the mice
by: Mohammad Reza Zarrindast, et al.
Published: (2009-04-01) -
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
by: Anjali K. Bhardwaj, et al.
Published: (2018-05-01) -
The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
by: Melissa A. Jackson, et al.
Published: (2021-07-01) -
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
by: Jeffrey Y. Hergenrather, et al.
Published: (2020-01-01)